Archives
Control of High Prescription Drug Costs
Finding a balance between drug affordability, access, and innovation remains a critical challenge.
Price Transparency
Healthcare transparency will continue to be a priority for federal policymakers.
Acceleration of Commercial Risk
Risk arrangements in the commercial market are accelerating.
Direct Contracting with Employers
Employers are directly contracting with healthcare providers to manage rising healthcare costs.
MA Doubles Down
Medicare Advantage, and the associated value-based care ecosystem will bounce back in 2025.
A New Era of Benefits Administration
Employers are adapting to rising healthcare costs through innovative benefits management strategies.
Disease- and Condition-Specific Payments
CMMI will increase focus on disease- and condition-specific models to improve care and reimbursement efficiency.
Fall of PSHPs
Provider sponsored health plans will be sold to traditional payors while health systems focus on core capabilities.